EVOK icon

Evoke Pharma
EVOK

15 hedge funds and large institutions have $2.94M invested in Evoke Pharma in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

22.36% more ownership

Funds ownership: 15.54% → 37.9% (+22%)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$792K
2
+$398K
3
+$386K
4
DS
DRW Securities
Illinois
+$118K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$93.2K

Top Sellers

1
-$33K
2
-$9.69K
3
-$792
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$792K
NCM
2
Nantahala Capital Management
Connecticut
$736K
BL
3
Bleichroeder LP
New York
$728K
NWMG
4
National Wealth Management Group
Ohio
$398K
DS
5
DRW Securities
Illinois
$118K
Vanguard Group
6
Vanguard Group
Pennsylvania
$93.2K
TSS
7
Two Sigma Securities
New York
$51.9K
Osaic Holdings
8
Osaic Holdings
Arizona
$16.4K
Northwestern Mutual Wealth Management
9
Northwestern Mutual Wealth Management
Wisconsin
$1.35K
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$1K
BlackRock
11
BlackRock
New York
$606
SS
12
SBI Securities
Japan
$378
TRCT
13
Tower Research Capital (TRC)
New York
$199
NA
14
NewEdge Advisors
Louisiana
$84
Bank of America
15
Bank of America
North Carolina
$60
Citadel Advisors
16
Citadel Advisors
Florida
–
Fidelity Investments
17
Fidelity Investments
Massachusetts
–